Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The University of Edinburgh has developed new methods for cleaning surgical instruments, which completely remove protein contamination, including prions - the infectious agents that cause Creutzfeldt-Jakob Disease (CJD) in humans. More
This invention relates to a novel radiotracer that has proven effective for use in SLN scintigraphy during the surgical detection and treatment of breast cancer More
This invention relates to a computer-controlled physiological flow simulator for use in the study of vascular hemodynamics and the calibration of clinical imaging systems used to measure blood flow More
Western researchers have developed a novel technique, Swallowing Air-Pulse Therapy (SWAPT) and an associated device Swallowing Air-Pulse Therapy System (SWAPTS). More
his invention concerns a system and method of obtaining four-dimensional (4-D) ultrasound images of moving tissue such as the human heart or lungs, where time is the fourth dimension. More
The current invention concerns a novel apparatus and method for the preparation of frozen tissue specimens for thin sectioning outside of the cryostat. More
Use of depth filters to remove prion infectivity from plasma - derived therapeutic products and/or other biologics. Depth Filtration is a chemically inactive process and therefore does not introduce potentially toxic bi-products or alter components. More
Proprietary manufacturing process for a liquid IVIgG product - in great demand world-wide as one of the principal therapeutics obtained from blood plasma. Process delivers a low IgA content, which increases renal tolerability. More
These inventions describe novel ultrasound systems and methods of obtaining high quality three-dimensional (3-D) images of a target volume. More
Proprietary process to produce a freeze-dried fibrinogen therapeutic product, easily soluble. Includes two virus inactivation processes: dry heat treatment and solvent/detergent. More
Your selection
Browse By
- Industry sector
- Antibody-based diagnostics
- Biomarker-based diagnostics
- CAT
- Genetic diagnostics
- Imaging
- MRI
- Nuclear medicine
- Other
- Self-test systems
- Supplies
- Test systems
- Ultrasound
- X-ray
- Therapeutic target
- Adhesion
- Anesthesia
- Bleeding
- Cosmetic surgery
- Dialysis
- Disinfectant
- Fibrosis
- General surgery
- Infection control
- Infusion
- Injection
- Intravenous
- Irrigation
- Perfusion
- Plasma expander
- Plasma substitute
- Surgery (other)
- Tissue grafting
- Transplantation
- Wound closure
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us